Clinuvel Pharmaceuticals Ltd. (CUVL) fundamentals score
American Depositary Receipts · Listed on NASDAQ
Overall: 6.8 out of 10, Good long-term fundamentals
- Growth: 4.6/10
- Profitability: 6.8/10
- Financial health: 9.3/10
- Earnings quality: 7.0/10
- Valuation: not scored
Scores are calculated from Clinuvel Pharmaceuticals Ltd.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other stocks
- Tal Education Group (TAL): 8.7/10
- American Public Education Inc. (APEI): 8.3/10
- New Oriental Education & Technology Group Inc. (EDU): 8.3/10
- Covista Inc. (CVSA): 8.0/10
- Imax Corp. (IMAX): 8.0/10
- Stride, Inc. (LRN): 8.0/10
- Laureate Education, Inc. (LAUR): 7.9/10
- Movado Group Inc. (MOV): 7.8/10